CoChat

The global burden and epidemiology of invasive non-typhoidal Salmonella infections

Open access

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Invasive non-typhoidal Salmonella (iNTS) disease has emerged as a major public health concern. Yet, understanding of the global burden is incomplete, limited particularly by the breadth of blood culture-based surveillance systems that are able to accurately diagnose the etiology of bacteremia. The accessibility of whole genome sequencing has allowed for genetic characterization of pathogens, shedding light on its evolutionary history and sounding alerts for its future progression. iNTS disease is observed to be a particular threat in sub-Saharan Africa, with a case fatality rate greatly exceeding that of typhoid fever, and commonly affecting infants, young children and immunocompromised adults. While iNTS disease might also be a threat in Asia and Latin America, its burden is not well characterized, primarily owing to the lack of comprehensive reporting in these regions. Drug-resistant Salmonella enterica (S. enterica) serovars (e.g. Typhimurium sequence type 313 (ST313)) have emerged as a potential consequence of sustained antibiotic pressure. Genetic analyses have identified distinguished iNTS disease-causing strains that are particularly virulent in certain human host populations. Effective treatment strategies, including vaccination, are necessary; iNTS vaccines targeting the most common S. enterica serovars, Typhimurium, Enteritidis and Dublin, are currently in early developmental stages. Funding and political support is needed to promote vaccine development and implementation programs to ultimately reduce the threat of iNTS disease in high risk areas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21645515.2018.1504717

Cites

33 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Disability-adjusted life years (DALYs) due to iNTS disease (2010). NOTE. Estimates only available at WHO regional-level; map should not be interpreted at the country-level. The full list of the WHO regional categorization (available in ref. 6) The DALY estimates may be conservative due to the exclusion of HIV infected individuals in the analysis.7
Figure 1. Disability-adjusted life years (DALYs) due to iNTS disease (2010). NOTE. Estimates only available at WHO regional-level; map should not be interpreted at the country-level. The full list of the WHO regional categorization (available in ref. 6) The DALY estimates may be conservative due to the exclusion of HIV infected individuals in the analysis.7CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 3

  1. Ao TT, 2015, Emerg Infect Dis, 21
  2. Kirk MD, Pires SM, Black RE, et al, 2015, von Seidlein L, ed, 12, e1001921
  3. Sinwat N, Angkittitrakul S, Coulson KF, Pilapil FM, Meunsene D, Chuanchuen R, 2016, J Med Microbiol, 65

Cited by

See all 261

Metadata

Authors
Balasubramanian, R., Im, J., Lee, J.-S., Jeon, H. J., Mogeni, O. D., Kim, J. H., Rakotozandrindrainy, R., Baker, S., & Marks, F.
Affiliations
  • Princeton University (US)
  • International Vaccine Institute (KR)
  • International Vaccine Institute, Seoul, Republic of Korea
  • University of Antananarivo (MG)
  • University of Cambridge (GB)
Corresponding author
Marks, Florian
Venue
Human Vaccines & Immunotherapeutics
Published
2018-09-05
Volume
15
Issue
6
Pages
1421-1426
ISSN
  • 2164-5515 (ISSN-L)
  • 2164-554X
OpenAlex
W2887144135
Cited by
261
References
33
Citations by year
2026: 35 · 2025: 62 · 2024: 38 · 2023: 33 · 2022: 34 · 2021: 31 · 2020: 22 · 2019: 6
FWCI
1.49
Type
journal article
Language
en
Open access
Locations
  • Human Vaccines & Immunotherapeutics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
Bill & Melinda Gates Foundation (OPP1127988)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
Keywords
invasive non-typhoidal Salmonella, Salmonella enterica, global burden, bacteremia, sub-Saharan Africa, case fatality rate, immunocompromised adults, children, antibiotic resistance, whole genome sequencing, vaccine development, Enteritidis, Dublin, typhoid fever
MeSH terms
Whole Genome Sequencing, Anti-Bacterial Agents, Humans, Salmonella Infections, Vaccination, Global Health, Bacteremia, Immunocompromised Host, Cost of Illness, Salmonella enterica, Salmonella Vaccines, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The global burden and epidemiology of invasive non-typhoidal Salmonella infections. https://app.cochat.ai/papers/10.1080/21645515.2018.1504717
The paper
Balasubramanian, R., Im, J., Lee, J.-S., Jeon, H. J., Mogeni, O. D., Kim, J. H., Rakotozandrindrainy, R., Baker, S., & Marks, F. (2019). The global burden and epidemiology of invasive non-typhoidal Salmonella infections. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2018.1504717

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.